Back to touchNEUROLOGY

touchCONGRESS Expert Opinions

Looking back over 2018: what have we learnt about optimizing the treatment of advanced Parkinson’s disease?

Menu

Introduction

Watch a series of internationally renowned clinical specialists from Europe discuss pivotal data for Parkinson’s disease from key neurology congresses throughout 2018 and consider how these findings may affect clinical practice.

The potential implications of these data for optimizing outcomes for patients with advanced Parkinson’s disease are explored from both global and regional perspectives.

The information in this activity is intended for neurologists, nurses and other healthcare professionals involved in the treatment of patients with Parkinson’s disease.

Learning Objectives

After watching these touchCONGRESS Expert Opinions from key neurology congresses during 2018, you should be able to:

  • Summarize the latest clinical data for emerging treatment options and treatment delivery systems for the management of motor and non-motor symptoms of Parkinson’s disease.
  • Discuss the use of biomarkers for the early identification of Parkinson’s disease, and to facilitate the use of neuroprotective agents.
  • Describe the use of emerging targeted agents and therapeutic strategies to manage treatment side effects and maintain patient quality of life.

Please feedback on this touchCONGRESS Expert Opinions on the following:
(scale 1-5, 1 strongly disagree; 5 strongly agree).